Maternal liver fibrosis indices as predictors of adverse perinatal outcomes in patients with gestational diabetes mellitus
- PMID: 40540213
- DOI: 10.1007/s00592-025-02547-7
Maternal liver fibrosis indices as predictors of adverse perinatal outcomes in patients with gestational diabetes mellitus
Abstract
Objective: This study aimed to evaluate the FIB-4 and APRI scores in patients with gestational diabetes mellitus (GDM) and investigate their associations with neonatal outcomes. Additionally, the predictive value of these non-invasive fibrosis indices for GDM and adverse perinatal outcomes was assessed.
Materials and methods: In this retrospective case-control study, 200 pregnant women diagnosed with GDM and 200 healthy controls were analyzed. Data on maternal demographics, laboratory parameters (ALT, AST, platelet count), FIB-4 and APRI scores, perinatal and neonatal outcomes including fetal growth restriction (FGR), oligohydramnios, polyhydramnios, birth weight, gestational age at birth, neonatal cord blood pH, neonatal hypoglycemia, Apgar 1 min. and 5 min. scores, and neonatal intensive care unit (NICU) admission were collected. Logistic regression analyses were performed to identify independent predictors of adverse perinatal outcomes among GDM patients. ROC analysis was used to determine the diagnostic performance of both indices.
Results: FIB-4 and APRI scores were significantly higher in GDM patients compared to controls (p < 0.05). Among GDM patients, those with FGR, NICU admission, or neonatal death had significantly elevated FIB-4 scores. Stratification by FIB-4 risk categories revealed that patients with high FIB-4 scores had increased rates of FGR, fetal hypoglycemia, adverse perinatal outcomes, and NICU admission (p < 0.01). ROC analysis for predicting GDM yielded AUC values of 0.577 for FIB-4 and 0.571 for APRI. For predicting adverse perinatal outcomes, the FIB-4 AUC was 0.590, while APRI showed limited predictive ability (AUC = 0.511).
Conclusion: FIB-4 can serve as a valuable non-invasive marker for liver dysfunction in GDM and is significantly associated with adverse perinatal outcomes. Despite limited predictive power, these scores may serve as early indicators of hepatic involvement in GDM.
Keywords: APRI; FIB-4 index; Gestational diabetes mellitus; Liver fibrosis; Neonatal outcomes.
© 2025. Associazione Medici Diabetologi / Association of Diabetologists (AMD), Societa Italiana di Diabetologia / Italian Society of Diabetology (SID).
Conflict of interest statement
Declarations. Conflict of Interest: The authors have no relevant financial or non-financial interests to disclose.
Similar articles
-
Leuko-Glycemic Index and Liver Fibrosis Markers in Gestational Diabetes Prediction: A Novel Perspective.Am J Reprod Immunol. 2025 Aug;94(2):e70136. doi: 10.1111/aji.70136. Am J Reprod Immunol. 2025. PMID: 40833284
-
Screening for gestational diabetes mellitus based on different risk profiles and settings for improving maternal and infant health.Cochrane Database Syst Rev. 2017 Aug 3;8(8):CD007222. doi: 10.1002/14651858.CD007222.pub4. Cochrane Database Syst Rev. 2017. PMID: 28771289 Free PMC article.
-
Impact of Gestational Diabetes on Neonatal Birth Weight and Maternal Postpartum Metabolic Changes.Cureus. 2025 Jun 15;17(6):e86060. doi: 10.7759/cureus.86060. eCollection 2025 Jun. Cureus. 2025. PMID: 40672007 Free PMC article.
-
Planned birth at or near term for improving health outcomes for pregnant women with gestational diabetes and their infants.Cochrane Database Syst Rev. 2018 Jan 5;1(1):CD012910. doi: 10.1002/14651858.CD012910. Cochrane Database Syst Rev. 2018. PMID: 29303230 Free PMC article.
-
Insulin for the treatment of women with gestational diabetes.Cochrane Database Syst Rev. 2017 Nov 5;11(11):CD012037. doi: 10.1002/14651858.CD012037.pub2. Cochrane Database Syst Rev. 2017. PMID: 29103210 Free PMC article.
References
-
- Foo RX, Ma JJ, Du R, Goh GBB, Chong YS, Zhang C et al (2024) Gestational diabetes mellitus and development of intergenerational non-alcoholic fatty liver disease (NAFLD) after delivery: a systematic review and meta-analysis. E Clin Med 72:102609
-
- Rager SL, Zeng MY (2023) The Gut-Liver Axis in pediatric liver health and disease, vol 11. Microorganisms, 3
LinkOut - more resources
Full Text Sources
Miscellaneous